Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

the Sequential Therapy of CD19-targeted and CD20-targeted CAR-T Cell Therapy for Diffuse Large B Cell Lymphoma(DLBCL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02737085
Recruitment Status : Unknown
Verified March 2016 by Jieping Chen, Southwest Hospital, China.
Recruitment status was:  Active, not recruiting
First Posted : April 13, 2016
Last Update Posted : September 7, 2016
Information provided by (Responsible Party):
Jieping Chen, Southwest Hospital, China

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : December 2019
Estimated Study Completion Date : December 2019